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Abstract
Behavioral models of cold responses are important tools for exploring the molecular mechanisms of cold sensation. To
complement the currently cold behavioral assays and allow further studies of these mechanisms, we have developed a new
technique to measure the cold response threshold, the cold plantar assay. In this assay, animals are acclimated on a glass
plate and a cold stimulus is applied to the hindpaw through the glass using a pellet of compressed dry ice. The latency to
withdrawal from the cooled glass is used as a measure of the cold response threshold of the rodents, and the dry ice pellet
provides a ramping cold stimulus on the glass that allows the correlation of withdrawal latency values to rough estimates of
the cold response threshold temperature. The assay is highly sensitive to manipulations including morphine-induced
analgesia, Complete Freund’s Adjuvant-induced inflammatory allodynia, and Spinal Nerve Ligation-induced neuropathic
allodynia.
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quantifies the magnitude of responses after the application of a
cold stimulus, as opposed to the minimal cold temperature capable
of generating a response (the cold response threshold).
Another commonly used test is the tail flick assay, in which the
latency of mice to withdraw their tails from cold water is measured
[12,14]. While the behavioral response is unambiguous, the
animals must be restrained during testing, which causes stress and
may alter results through well–known stress-induced analgesic
mechanisms [15].
Another model, the cold plate assay, assesses the behavior of
mice after they are placed on a pre-cooled plate [16,17,18].
Investigators have used metrics including the number of jumps
[13,16], the latency to first response [13,16,19,20], and the
number of paw lifts [13,21,22], but there is no consensus on the
meaning of each parameter. Furthermore, only one temperature
can be tested at a time. As with the acetone test, the cold plate does
not assess a precise temperature capable of generating a response,
but measures the magnitude of the response.
A related technique, the 2 temperature choice test, measures the
preference of an animal between two temperature-controlled
plates, typically a control temperature and a cold temperature.
The time spent on each plate is thought to reflect the animal’s
temperature preferences over a long period, as opposed to the
spinal reflexes measured in the assays described above. One
limitation of this assay is that the data reflects preference rather
than aversion, and is therefore difficult to interpret physiologically.
It is also time and manpower intensive, requiring multiple trials at
every temperature to generate a full temperature response curve.

Introduction
In every field of medicine, pain is a significant issue [1,2]. One
clinically important subset of pain is aberrant cold perception,
which affects broad patient populations including multiple sclerosis
[3], chemotherapy [4,5,6], and stroke patients [7,8]. These
patients experience alterations in cold sensitivity that profoundly
impact their quality of life, including alterations of the cold
response threshold (cold allodynia) and of the severity of the
evoked sensation (cold hyperalgesia)[3,7,9,10]. Treatment options
for these patients are limited, in part because the pathologic
changes leading to alterations in cold sensitivity are poorly
understood. The ability to treat these conditions should improve
as the molecular mechanisms of cold pain and sensitization
become better understood. Progress in understanding these
mechanisms has been slowed by limitations in the behavioral
assays used to study animal models of aberrant cold perception,
suggesting that new, complementary assays are necessary.
One common model, the acetone evaporation test [11,12],
involves dabbing the hindpaw with acetone, which evaporates and
cools the paw. The time the mouse spends flicking the paw
afterwards is used as a measure of cold sensitivity. While this
method has been a mainstay of investigations and has led to
important discoveries, there are several limitations. The test is
confounded by the odor of acetone on the paw, and naive mice
have no response, which limits the test’s utility in measuring cold
anesthesia. Additionally, while the acetone cooling has been
quantified [13], it is difficult to ensure that the exact same amount
of acetone is applied to generate a consistent stimulus, and
impossible to modulate the rate of cooling. Additionally, this assay
PLoS ONE | www.plosone.org
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To complement the currently used assays and accurately
measure cold response threshold, we developed a novel technique,
the cold plantar assay. Mice are acclimated on glass, a pellet of
compressed dry ice powder is applied to the glass below the paw,
and the latency to withdrawal from the cooling glass is measured.
We demonstrate that this method delivers a consistent ramping
cold stimulus to acclimated, unrestrained mice.

Methods
Animals
All mouse protocols were in accordance with National Institutes
of Health guidelines and were approved by the Animal Studies
Committee of Washington University School of Medicine (St.
Louis, MO). All experiments were carried out with 6–8 week old
male Swiss Webster mice (Jackson Labs, Bar Harbor, ME) except
for 6–8 week old male C57/Bl6 mice used in Figure 2B, which
were bred in-house. Mice were housed on a 12/12 hour light/dark
cycle with the light cycle beginning at 6 a.m. All mice had ad
libitum access to rodent chow and water.

Data analysis
All data were collated in.xlsx files using Microsoft Excel 2011
and analyzed using Graphpad Prism from Graphpad Software (La
Jolla, CA). Unless otherwise noted, all error bars shown represent
the standard error of the mean.
Figure 1. The Cold Plantar Assay. A. Grind dry ice into a fine
powder with a hammer (panel 1). Load the dry ice powder into a 3mL
syringe and compress against a flat surface until powder cannot be
compressed any further (panel 2). Using the syringe plunger, push the
dry ice pellet 20–30mm past the tip of the syringe (panel 2). Gently but
firmly apply the flat end of the dry ice pellet to the glass surface
underneath the paw of the mouse (panel 3) and measure the latency to
withdrawal with a stopwatch. B. Schematic of the cold plantar assay
apparatus. Mice are acclimated in plastic enclosures on a glass plate. A
mirror is placed underneath the apparatus to facilitate targeting of the
dry ice probe.
doi:10.1371/journal.pone.0039765.g001

Behavioral analysis
All behavioral tests and analyses were conducted by an
experimenter blind to treatment. Behavioral tests were performed
between 1pm and 5 p.m. local time unless the experimental design
required baseline measurements in the morning (CFA injection
only). All experiments were performed at 22uC.

Cold plantar assay
1/80, 3/160, and 1/40 thick pyrex borosilicate float glass was
acquired from Stemmerich, Inc (St. Louis, MO). Mice were
acclimated on the glass plate in transparent plastic enclosures
(406406110) separated by opaque black dividers for 2.5–3 hours.
The lighting was undimmed to maintain the light/dark cycle and a
white noise generator was used to mask external noise.
To make the cold probe, freshly delivered dry ice was crushed
into a fine powder using a hammer and stored at 280uC. To
shape the probe, a razor blade was used to cut the top off a 3mL
BD syringe (Franklin Lakes, NJ), and a BD needle tip was used to
make 3 holes on each side of the syringe to prevent gas buildup
inside the syringe body. The powdered dry ice was packed into the
modified syringe and the open end of the syringe was held against
a flat surface while pressure was applied to the plunger to compress
the dry ice into a flattened, dense pellet 1 cm in diameter (Figure 1).
Mice at rest but not asleep were tested by extending the tip of
the dry ice pellet past the end of the syringe and pressing it to the
glass underneath the hindpaw using light pressure but consistent
pressure applied to the syringe plunger (Figure 1). The center of
the hindpaw was targeted, taking care to avoid the distal joints and
ensuring that the paw itself was actually touching the glass surface
(Figure 1).
The withdrawal latency was measured with a stopwatch.
Withdrawal was defined as any action to move the paw vertically
or horizontally away from the cold glass. An interval of at least
7 minutes was allowed between testing separate paws on a single
mouse, and an interval of at least 15 minutes was allowed between
trials on any single paw. These intervals were chosen empirically
to allow enough time for the average mouse to return to a resting
PLoS ONE | www.plosone.org

state after stimulation. For baseline experiments, mice were
measured at least 3 times per paw. For experiments with an
experimentally limited time window, 1–2 measurements per paw
were made per timepoint.
The maximum time allowed for withdrawal was 20 seconds to
avoid potential tissue damage, based on animal behavior in
preliminary trials; in early tests, mice that endured longer that
20 second stimulations responded with exaggerated nocifensive
behaviors and would often prevent additional testing on that paw
by not placing it on the glass. Trials where the animal did not
withdraw in under 20 seconds were repeated. If the second trial
also yielded no withdrawal within the cutoff, the value was
recorded as 20 seconds.

Acetone evaporation assay
The acetone evaporation assay was performed as described
previously [23]. Briefly, mice were acclimated for 3 hours on a
wire mesh. After acclimation, acetone was drawn into a 1mL
syringe and dabbed onto the plantar surface of the hindpaw. The
first 10 seconds of activity were disregarded as a response to the
direct application of the droplet [23], and the time spent flicking or
licking the paw for 60 seconds afterwards was measured with a
stopwatch.
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Thermometer from Extech Instruments (Waltham, MA). The data
were output into CSV files which were loaded into Microsoft
Excel.xlsx files and analyzed using Graphpad Prism from
Graphpad Software (La Jolla, CA).
To measure temperature readings on the glass, Swiss Webster
mice were lightly anesthetized using a cocktail of Ketamine (final
concentration 38 mg/mL Fort Dodge Animal Health, Fort Dodge
IA), Xylazine (final concentration 1.92 mg/mL Lloyd Labs
Shenandoah, IA) Acepromazine (final concentration 0.38 mg/
mL Butler Schein Animal Health Dublin, OH). The T-type
thermocouple filament was secured to the mouse paw with a loop
of laboratory tape. The paw was then taped to the glass and gently
held flush to the glass surface. A dry ice pellet was generated as
described above and held to the underside of the glass in the target
area for a proscribed amount of time and the change in
temperature was tracked with the EA15 Data Logger. This
analysis was performed on each of the 3 thicknesses of glass (1/80,
3/160, 1/40). Temperature measurements were also performed
using a Hargreaves glass apparatus from IITC Life Sciences
(Woodland Hills, CA) where the active intensity was engaged as
soon as the light was focused onto the paw to avoid premature
warming from the resting intensity beam. The light stimulus was
applied for the average withdrawal latency with the active intensity
of 15% (10 seconds).

Morphine studies
Morphine sulfate from Baxter Healthcare (Deerfield, IL) was
diluted in saline and injected subcutaneously at a final dosage of
1.5mg/kg to induce short-term anesthesia. Mice were injected
with either morphine or saline vehicle, and the experimenter was
blind to the contents of each syringe until after data analysis. No
mice were excluded from analysis. Mice were acclimated as above,
and 3 baseline measurements of withdrawal latency to cold
stimulus for the right paw were taken for each mouse. The mice
were then injected subcutaneously with either the morphine or a
saline control and measurements of withdrawal latency were taken
from the right paw of each animal every 30 minutes until all mice
returned to baseline latency values.
Figure 2. The Cold plantar assay applies a consistent ramping
cold stimulus. A. The cold plantar withdrawal latency increases as
thicker glass plates are used. With Swiss Webster mice, on the 1/80 glass
the average latency is 3.7960.5 seconds, on the 3/160 glass the average
latency is 7.2960.9 seconds, and on the 1/40 glass the average latency is
11.6361.3 seconds. The average latencies on each glass are significantly
different (1-way ANOVA with Bonferroni post-hoc test ***p,.0001
between all thicknesses; n = 12 mice per glass). B. With C57 mice, on the
1/80 glass the average latency is 3.8360.5 seconds, on the 3/160 glass
the average latency is 7.061.4 seconds, and on the 1/40 glass the
average latency is 10.460.9 seconds. The average latencies on each
glass are significantly different (1-way ANOVA with Bonferroni post-hoc
test ***p,.0001 between all thicknesses; n = 10 mice per glass). C.
Schematic showing how the temperature between the paw and the
glass was measured. D. Curves representing the change in temperature
between the paw and the glass during and shortly after dry ice
stimulation. For each curve, the dry ice stimulus begins at x = 1, and
ends at the colored arrow for that thickness (from 2A, 1/80: 3.79
seconds, 3/160: 7.29 seconds, 1/40: 11.63 seconds). Based on these
curves, mice withdraw after a 1.3uC (1/80), 1.5uC (3/160), or 2uC (1/40)
change in temperature (n = 6 per glass thickness).
doi:10.1371/journal.pone.0039765.g002

Complete Freund’s Adjuvant (CFA) studies
Twenty microliters of Complete Freund’s Adjuvant from
Sigma-Aldrich (St. Louis, MO) or 0.9% Saline from Hospira,
Inc (Lake Forest, IL) was injected into the right hindpaw of each
mouse. The experimenter was blind to the contents of each syringe
until after data analysis was completed. No mice were excluded
from analysis. Mice were acclimated as described above and 3–5
baseline measurements of withdrawal latency for each paw were
taken for each mouse. Each mouse was then injected in the right
hindpaw with either CFA or saline and measurements of cold
plantar withdrawal latency on both paws were measured at
1 hour, 2 hours, and 3 hours post-injection. At 4 hours post
intraplantar injection, all mice were given subcutaneous injections
of 1.5mg/kg morphine and the withdrawal latency was measured
at 4.5, 5, and 5.5 hours post intraplantar injection. Finally,
withdrawal latency measurements were also made at 24 and
48 hours post-intraplantar injection.

Spinal nerve ligation (SNL) model
The spinal nerve ligation procedure was performed as described
previously [24,25]. The experimenter was blinded to the surgical
procedure received by each mouse until after data analysis was
completed. No mice were excluded from analysis. Briefly, baseline
measurements of cold plantar withdrawal latency and acetone
evaporation response time were made on all mice. The mice were

Glass temperature measurements
Temperature values on the glass surface were measured using
an IT-24P filament T-type thermocouple probe from Physitemp
Instruments, Inc. (Clifton, NJ) and the temperatures were collected
once every second using an EA15 Data-Logging Dual Input
PLoS ONE | www.plosone.org
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Figure 3. The cold plantar assay requires direct paw-glass contact. A. Schematic diagramming the experimental design. B–D. The
temperature during cold plantar stimulus underneath the paw was measured on all three glass thicknesses under normal conditions, and with
styrofoam spacers propping the paw away from the glass surface. In all cases, propping the paw away from the glass caused a dramatic decrease in
the cold stimulus measured at the paw (n = 6 per glass thickness). E. The temperature underneath the paw was measured during Hargreaves radiant
heat stimulation with the paw propped up with styrofoam. Unlike the cold plantar assay, the thermal stimulus in the Hargreaves assay is largely
unaltered when the paw is propped away from the glass (n = 6).
doi:10.1371/journal.pone.0039765.g003

then deeply anesthetized with the ketamine cocktail described
above, and the paraspinal muscles were bluntly dissected to expose
the left L5 transverse process. Mice receiving the full ligation
procedure had the L5 process removed, and the left L4 spinal
nerve was tightly ligated with silk suture (6-0, Ethicon; Cornelia,
GA) and transected distal to the ligation. Mice receiving a sham
surgery had the L5 transverse process exposed, but not removed
and the nerve was untouched.

PLoS ONE | www.plosone.org

The cold plantar withdrawal latency was then measured 3, 6,
and 10 days after surgery. The time spent responding to acetone
evaporation was measured 2, 5, and 11 days after surgery. After
the baseline measurements on days 10/11, on both days the mice
were injected subcutaneously with 1.5mg/kg morphine and either
cold plantar withdrawal threshold or acetone response time was
measured 30, 60, and 90 minutes after morphine injection.
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Figure 4. The cold plantar assay can measure analgesia and
allodynia. A. Mice were given subcutaneous injections of 1.5mg/kg
morphine or saline. Thirty minutes after injection, morphine-injected
mice had significantly higher withdrawal latencies on the 1/40 glass, but
60 minutes after injection the morphine injected mice had returned to
baseline latency values (2-way ANOVA main effect *p,0.05 with
Bonferroni post-hoc test; 30 minutes **p,0.01; n = 12 per group). B.
Mice were given intraplantar injections of Complete Freund’s Adjuvant
or saline. 2 and 3 hours after injection, CFA-injected mice had
significantly lower withdrawal latencies on the 1/40 glass than the
saline-injected controls (2-way ANOVA main effect p,.0001 with
Bonferroni post-hoc test; 120 minutes *p,0.05, 180 minutes
**p,0.01 n = 12 per group). 4 hours after intraplantar injection, all
animals were given subcutaneous injections of 1.5mg/kg morphine. At
4.5 hours both CFA- and Saline-injected animals had significantly
increased withdrawal latencies compared to their values at 3 hours (1way ANOVA with Dunnett’s post-hoc test; CFA 3hours vs. CFA 4.5 hours
$$$ p,0.0001, Saline 3 hours vs. Saline 4.5 hours $$$ p,0.0001). At 5.5
hours, the CFA-injected mice had significantly lower withdrawal
latencies than their saline-injected counterparts (2-way ANOVA with
Bonferroni post-hoc test; 5.5 hours **p,0.01). 24 hours after intraplantar injection, the CFA-injected mice still had significantly lower
withdrawal latencies than their saline-injected counterparts, but this
difference resolved by 48 hours (2-way ANOVA with Bonferroni posthoc test; 24 hours ** p,0.01, 48 hours p.0.05).
doi:10.1371/journal.pone.0039765.g004

PLoS ONE | www.plosone.org

Figure 5. The cold plantar assay can measure L4 spinal nerve
ligation induced allodynia. Mice underwent the spinal nerve
ligation (SNL) procedure or a sham procedure on day 0. A. On days 3,
6, and 10 post surgery SNL mice had significantly lower cold plantar
withdrawal latencies on the 1/40 glass than sham mice (2-way ANOVA
main effect ***p,0.001 with Bonferroni post-hoc test; 3d ***p,0.001,
6d **p,0.01, 10d **p,0.01; Sham n = 5, SNL n = 6). After baseline
measurements on day 10 post surgery, mice were injected with 1.5mg/
kg morphine. Thirty minutes after morphine injection, both SNL and
sham mice had withdrawal latencies that were significantly elevated
from their baseline values that day (1-way ANOVA with Dunnett’s posthoc test; Sham $ p,0.05, SNL $$ p,0.01). By 90 minutes after morphine
injection, the SNL mice again had significantly decreased withdrawal
latencies than the sham mice (2-way ANOVA with Bonferroni post-hoc
test; ***p,0.001). B. On days 2, 5, and 11 post surgery SNL mice spent
more time flicking after acetone application than sham mice (2-way
ANOVA main effect *p,0.05 with Bonferroni post-hoc test; 2 days
p.0.05, 5 days p.0.05, 11 days p.0.05). After baseline measurements
on day 11 post surgery, mice were injected with 1.5mg/kg morphine.
There was a significant reduction in the time responding to acetone in
the SNL group but not in the Sham group (1-way ANOVA with
Dunnett’s post-hoc test; Sham p.0.05, SNL $$ p,0.01).
doi:10.1371/journal.pone.0039765.g005
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and found that the radiant heat stimulus was unaffected by the
separation of the paw from the glass (Figure 3E).

Results
Mice respond to consistent changes in temperature in
the cold plantar assay

Morphine-induced anesthesia

To measure the cold response threshold of mice to a cold
stimulus, we apply a compressed dry ice pellet underneath the
hindpaw as it rests on a glass plate as depicted in Figure 1.
Condensation generally appeared on the glass after stimulation,
but not during. Application of the dry ice pellet resulted in a
number of nocifensive responses. Typical responses from mice at
rest but not asleep included lifting of the paw followed by a
combination of flicking, licking, or biting the paw lasting 1 second
to one minute after cessation of the stimulus and/or movement
away from the stimulus area. The latency to withdrawal from the
cooled glass is used as a surrogate for the temperature at which the
mice responded to the cold stimulus. This latency is dependent on
the thickness of the glass plate. We measured the cold threshold
response in naı̈ve Swiss Webster mice on 1/80, 3/160, and 1/40
thick glass. Latency for a mouse to remove its hindpaw from the
glass surface was lowest for the 1/80 plate (3.7960.5 seconds), and
increased as the thickness increased to 3/160 (7.2960.9 seconds)
and then 1/40 (11.6361.3 seconds) (Figure 2A 1-way ANOVA
with Bonferroni post-hoc test ***p,0.0001 for all comparisons;
n = 12 per glass). The average cold plantar withdrawal latency of
C57/Bl6 mice on all three thicknesses was also measured
(Figure 2B 1/80 plate average: 3.8360.5s, 3/160 plate average:
7.061.4s, 1/40 plate average: 10.460.9s 1-way ANOVA with
Bonferroni post-hoc test ***p,0.0001 for all comparisons).
After establishing consistent withdrawal latencies on each glass
thickness, we anesthetized mice and positioned their paws over a
filament thermocouple probe on the glass (Figure 2B) to measure
the temperature between the paw and the glass during the cold
stimulus used in this. To mimic experimental conditions, the cold
stimulus was applied for the average latency to withdrawal for
each thickness. In other words, we applied the stimulus for
4 seconds for 1/80 thick glass (Figure 2C, light blue triangles,
arrow at 4 seconds), 7 seconds for 3/160 thick glass
(Figure 2C, royal blue squares, arrow at 7 seconds),
and 10 seconds for 1/40 thick glass (Figure 2C, dark blue
circles, arrow at 10 seconds). On the 1/80 glass, the
temperature between paw and glass after 4 seconds of stimulation
was decreased by 1.3uC. (Figure 2C n = 6). On the 3/160 thick
glass, the temperature between the paw and the glass after 7
seconds of stimulation was decreased by 1.5uC (Figure 2C n = 6).
On the 1/40 thick glass, the temperature between the paw and the
glass after 10 seconds of stimulation was decreased by 2uC
(Figure 2C n = 6). When the dry ice stimulus is maintained on the
glass plates past these average withdrawal times, the temperature
continues to decrease rapidly and can reach temperatures below
25uC (data not shown). We also performed this temperature
measurement analysis using the conventional radiant heat
apparatus (IITC; Woodland Hills, CA) with a pre-heated glass
plate, and found that after 10 seconds of radiant thermal
stimulation (the average stimulus capable of causing withdrawal
under these conditions) the temperature between the glass and the
paw increased by 4.3uC (Figure 2C n = 6).
Next we tested whether direct contact of the paw with the glass
surface is required to generate a consistent cold stimulus. To test
this, we used thin styrofoam spacers to incrementally separate the
paw and thermocouple from the glass surface while applying the
cold stimulus (Figure 3A n = 6 per group). When the paw is
separated from the glass surface, the cold stimulus from the dry ice
pellet is drastically attenuated (Figure 3B–D). We also performed
this analysis using the Hargreaves apparatus on a pre-heated plate,
PLoS ONE | www.plosone.org

After 3–5 baseline measurements of cold plantar withdrawal
latency were made on each animal, transient anesthesia was
induced with subcutaneous injections of 1.5mg/kg morphine over
the coccyx. Cold plantar withdrawal latency measurements on the
1/40 glass were taken on the right hindpaw at 30, 60, and
90 minutes after injection of the morphine or a saline control. All
testing and analysis was done while blinded to treatment. The
latency to withdraw was significantly increased after 30 minutes
for the morphine-injected group compared to the saline-injected
group (Figure 4A 2-way ANOVA main effect *p,0.05 with
Bonferroni post-hoc test; 30 minutes **p,0.01; n = 12 per group).
By 60 minutes post-injection the latency to withdraw returned to
baseline levels (Figure 4A 2-way ANOVA with Bonferroni posthoc test; 60 minutes p.0.05), consistent with the typical rate of
morphine metabolism in mice [26].

Complete Freund’s Adjuvant (CFA)-induced
hypersensitivity
After 3–5 baseline measurements of cold plantar withdrawal
latency were made on each animal, inflammation was induced
with intraplantar injections of 20mL CFA. Using the 1/40 glass, the
cold plantar withdrawal latency was measured on both hindpaws
(injected and contralateral) at 1, 2, and 3 hours after injection with
CFA or a saline control. 4 hours after CFA injection, all mice were
injected with 1.5mg/kg morphine and withdrawal latencies were
measured at 4.5, 5, and 5.5 hours. Over the following two days,
paw withdrawal latencies were measured 24 and 48 hours after
CFA injection. After 120 and 180 minutes, the latency to
withdraw significantly decreased in the mice injected with CFA
compared to mice injected with saline (Figure 4B 2-way ANOVA
main effect p,.0001 with Bonferroni post-hoc test; 120 minutes
*p,0.05, 180 minutes **p,0.01 n = 12 per group). At 4.5 hours,
30 minutes after the subcutaneous injection of morphine, the
latency to withdraw of both groups of mice increased significantly
compared with their respective latencies before the morphine
injection (Figure 4B 1-way ANOVA with Dunnett’s post-hoc test;
CFA 3 hours vs. CFA 4.5 hours $$$p,0.0001, Saline 3 hours vs.
Saline 4.5 hours $$$p,0.0001). At 5 hours after intraplantar
injections (60 minutes after morphine injection), neither group was
significantly different from the withdrawal latencies at 3 hours
(Figure 4B 1-way ANOVA with Dunnett’s post-hoc test; CFA
and Saline p.0.05). By 5.5 hours after intraplantar injection (90
minutes after morphine injection), the withdrawal latencies of the
mice injected with CFA were significantly lower than those of mice
injected with saline (Figure 4B 2-way ANOVA with Bonferroni
post-hoc test; 5.5 hours **p,0.01). The cold hypersensitivity that
was induced by CFA injection was maintained for 24 hours
(Figure 4B 2-way ANOVA with Bonferroni post-hoc test; CFA
** p,0.01), but returned to the same values as the saline-injected
mice by 48 hours (Figure 4B 2-way ANOVA with Bonferroni
post-hoc test; p.0.05). Contralateral paw withdrawal latencies
were measured at all time points, and were unchanged by
experimental manipulations (data not shown).

Spinal nerve ligation-induced hypersensitivity
After 3–5 baseline measurements of cold plantar withdrawal
latency using the 1/40 thick glass as well as the acetone
evaporation test were made on each animal, nerve injury was
induced using the left L4 spinal nerve ligation (SNL) procedure
6
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[24,25] on 6 week-old male Swiss Webster mice (Figure 5). After
acetone application the amount of time spent flicking was
significantly increased in the SNL mice compared to the sham
mice, but no individual time points showed increases at 2, 5, or 11
days after surgery showed increases that were statistically
significant in post-hoc tests (Figure 5B 2-way ANOVA main
effect *p,0.05 with Bonferroni post-hoc test; 2 days p.0.05, 5
days p.0.05, 11 days p.0.05; Sham n = 5, SNL n = 6). When
tested with the cold plantar assay, the same SNL mice yielded a
significant main effect of SNL treatment leading to lower
withdrawal latencies, and also had decreases in latencies at 3, 6,
and 10 days after surgery that were statistically significant by posthoc tests (Figure 5A 2-way ANOVA main effect ***p,0.001 with
Bonferroni post-hoc test; 3 days ***p,0.001, 6 days **p,0.01, 10
days **p,0.01).
Ten days after surgery, cold plantar withdrawal latencies were
measured and then 1.5mg/kg morphine was injected subcutaneously. Cold plantar assay measurements were taken at 30, 60, and
90 minutes after injection. Both sham and SNL groups showed
increased withdrawal latencies 30 minutes after morphine injection (Figure 5A 1-way ANOVA with Dunnett’s post-hoc test;
Sham $$p,0.05, CFA $p,0.05), and both groups returned to
their respective baseline values by 60 minutes after morphine
(Figure 5A 2-way ANOVA with Bonferroni post-hoc test;
***p,0.001).
Eleven days after surgery, acetone evaporation baselines were
measured and then 1.5mg/kg morphine was injected subcutaneously. Acetone evaporation measurements were taken at 30, 60,
and 90 minutes after injection. There was a significant reduction
in the time responding to acetone in the SNL group but not in the
Sham group (Figure 5B 1-way ANOVA with Dunnett’s post-hoc
test; SNL 30 minutes and 60 minutes $$p,0.05, Sham p.0.05).
Contralateral paw withdrawal latencies were measured at all time
points, and were unchanged by experimental manipulations (data
not shown).

with their paws on the glass. While testers should be wary of
guarding or changes in weight distribution that may occur after
injury, we have found that consistent measurements can be made
even in both inflammatory and nerve-injury models (Figures 4,
5).
It was surprising to note that naı̈ve mice withdraw from
temperature decreases ranging between 1.3–2uC. Furthermore,
our data using the Hargreaves apparatus also show that naı̈ve mice
withdraw after an increase of just 4–5uC, which is much smaller
than previously reported values [27]. Based on these data, we
conclude that a relatively small change in temperature is sufficient
to generate a nocifensive response. That such small temperature
changes elicit robust behavioral responses may suggest the
nociceptive system is capable of responding to non-noxious
temperature changes, or that withdrawal can be elicited by
mechanisms that anticipate the potential severity of future insults
and responds to prevent serious damage. This latter possibility is
supported by several classical studies showing that the heat pain
threshold is affected by the rate of heating [28,29], which suggests
the possibility that cold pain thresholds follow a similar principle.
This notion is also supported by single unit recordings from
cutaneous nociceptors showing that while nociceptive neurons fire
bursts during cooling ramps, the firing rate decreases when the
skin is held at a cold temperature for sustained periods [30,31].
The molecular mechanisms of cold sensation and nociception
have been hotly debated over the last decade, most notably over
the roles of TRPM8 and TRPA1. Initial studies [17,20] using the
acetone evaporation test, cold plate test, and the 2 temperature
choice tests showed no role for TRPA1 in cold sensation.
However, studies [16,22] published nearly simultaneously by
other groups used the same assays and found that TRPA1 has a
significant role in cold sensation. Part of the conflict may arise
from ambiguities in interpreting the data from these assays; for
example, in the cold plate test the one group measured the number
of flinches [17,20] but another group measured the number of paw
lifts [22] and a third measured the latency to jump and the number
of jumps [16]. The cold plantar assay, which yields an easily
quantified and unambiguous behavioral response, will complement the previously available techniques and aid in addressing
these controversies. This new technique will allow the consolidation of the work of the last decade, and enable further progress in
understanding and manipulating the molecular mechanisms that
underlie cold nociception, allowing for the development of new,
targeted therapeutic agents.

Discussion
We have demonstrated that the cold plantar assay allows the
application of a consistent focal ramping cold stimulus to
unrestrained, acclimated mice. This assay can measure both cold
allodynia and cold anesthesia under baseline conditions with
relatively low variability in mice in a way that was not possible
using previously available techniques, such as the acetone
evaporation test. It is also highly sensitive to procedures that alter
the cold responses of mice including morphine, CFA-induced
inflammation, and SNL-induced nerve injury.
In the cold plantar assay, we found that the paw being tested
had to be in direct contact with the glass surface to maintain a
consistent cold stimulus. Interestingly enough, our parallel studies
with the radiant heat assay show that it does not share this
requirement, as the stimulus delivered to the paw is largely
unchanged whether the paw is in contact with the glass or not.
The requirement for direct contact of the paw with the glass in the
cold plantar assay is not an issue as acclimated mice typically rest
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